Tag: patent challenge

Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Market Entry

Dec, 15 2025| 1 Comments

Paragraph IV certifications let generic drugmakers challenge brand-name patents before launch, speeding up cheaper alternatives. This legal tool under the Hatch-Waxman Act has saved consumers trillions and reshaped pharmaceutical competition.